Gene · 406994
Papers1,782
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,782
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Domain architecture and protein-protein interactions regulate KDM5A recruitment to the chromatin. | Epigenetics | 2023 | 37838974 | PubTator, text mining | PubMed |
| The Role of the Dysregulation of Long Non-Coding and Circular RNA Expression in Medulloblastoma: A Systematic Review. | Cancers (Basel) | 2023 | 37835380 | PubTator, text mining | PubMed |
| TTK is a potential regulator of tumor progression correlated with dedifferentiation and immune cell infiltration in papillary thyroid cancer. | Aging (Albany NY) | 2023 | 37815894 | PubTator, text mining | PubMed |
| Unraveling the Complex Interplay between Epigenetics and Immunity in Alcohol-Associated Liver Disease: A Comprehensive Review. | Int J Biol Sci | 2023 | 37781509 | PubTator, text mining | PubMed |
| Hsa_circ_0119412 is a tumor promoter in hepatocellular carcinoma by inhibiting miR-526b-5p to upregulate STMN1. | Cancer Biol Ther | 2023 | 37773733 | PubTator, text mining | PubMed |
| Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential. | Cardiovasc Diabetol | 2023 | 37749569 | PubTator, text mining | PubMed |
| Identification and verification of a prognostic signature based on a miRNA-mRNA interaction pattern in colon adenocarcinoma. | Front Cell Dev Biol | 2023 | 37745305 | PubTator, text mining | PubMed |
| Preclinical Evidence for the Use of Oral Mesenchymal Stem Cell-Derived Extracellular Vesicles in Bone Regenerative Therapy: A Systematic Review. | Stem Cells Transl Med | 2023 | 37715961 | PubTator, text mining | PubMed |
| Altered microRNA expression in patients with sarcoidosis. | Sarcoidosis Vasc Diffuse Lung Dis | 2023 | 37712378 | PubTator, text mining | PubMed |
| LncRNA PTTG3P promotes tumorigenesis and metastasis of NSCLC by binding with ILF3 to maintain mRNA stability and form a positive feedback loop with E2F1. | Int J Biol Sci | 2023 | 37705754 | PubTator, text mining | PubMed |
| Circular RNA vaccine in disease prevention and treatment. | Signal Transduct Target Ther | 2023 | 37691066 | PubTator, text mining | PubMed |
| Novel Insights into the Molecular Mechanisms of Atherosclerosis. | Int J Mol Sci | 2023 | 37686238 | PubTator, text mining | PubMed |
| Shared Molecular Pathways in Glaucoma and Other Neurodegenerative Diseases: Insights from RNA-Seq Analysis and miRNA Regulation for Promising Therapeutic Avenues. | Cells | 2023 | 37681887 | PubTator, text mining | PubMed |
| FOXP2 confers oncogenic effects in prostate cancer. | Elife | 2023 | 37668356 | PubTator, text mining | PubMed |
| Preliminary study on miRNA in prostate cancer. | World J Surg Oncol | 2023 | 37641123 | PubTator, text mining | PubMed |
| Delivery of RNA to the Blood-Brain Barrier Endothelium Using Cationic Bicelles. | Pharmaceutics | 2023 | 37631300 | PubTator, text mining | PubMed |
| 3D Culture and Interferon-γ Priming Modulates Characteristics of Mesenchymal Stromal/Stem Cells by Modifying the Expression of Both Intracellular and Exosomal microRNAs. | Biology (Basel) | 2023 | 37626949 | PubTator, text mining | PubMed |
| Drug Discovery and Development of miRNA-Based Nucleotide Drugs for Gastrointestinal Cancer. | Biomedicines | 2023 | 37626731 | PubTator, text mining | PubMed |
| Clinical Theragnostic Signature of Extracellular Vesicles in Traumatic Brain Injury (TBI). | ACS Chem Neurosci | 2023 | 37624044 | PubTator, text mining | PubMed |
| Corrigendum: miR-212/132-enriched extracellular vesicles promote differentiation of induced pluripotent stem cells into pancreatic beta cells. | Front Cell Dev Biol | 2023 | 37601100 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406994/papers?page=4